MB
MPM BioImpact Portfolio holdings
AUM
$577M
This Quarter Return
+3.74%
1 Year Return
+8.33%
3 Year Return
+241.63%
5 Year Return
+127.38%
10 Year Return
–
AUM
$644M
AUM Growth
+$644M
(+3.5%)
Cap. Flow
+$93.3M
Cap. Flow
% of AUM
14.5%
Top 10 Holdings %
Top 10 Hldgs %
53.54%
Holding
47
New
9
Increased
25
Reduced
4
Closed
3
Top Buys
| 1 |
Mirum Pharmaceuticals
MIRM
|
$16.8M |
| 2 |
Guardant Health
GH
|
$14.4M |
| 3 |
Alkermes
ALKS
|
$13.4M |
| 4 |
Lantheus
LNTH
|
$12M |
| 5 |
HilleVax
HLVX
|
$9.33M |
Top Sells
| 1 |
Geron
GERN
|
$34.6M |
| 2 |
Viridian Therapeutics
VRDN
|
$10.8M |
| 3 |
Amicus Therapeutics
FOLD
|
$8.47M |
| 4 |
Sutro Biopharma
STRO
|
$3.09M |
| 5 |
Viking Therapeutics
VKTX
|
$1.65M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Akero Therapeutics
AKRO
$3.65B
| $9.06M | 1.41% |
385,990
+53,066
| +16% | +$1.24M |
|
27
89bio
ETNB
$1.37B
| $8.99M | 1.4% |
1,121,736
+153,994
| +16% | +$1.23M |
|
28
Fulcrum Therapeutics
FULC
$353M
| $8.96M | 1.39% |
1,444,851
+307,743
| +27% | +$1.91M |
|
|
29
Sutro Biopharma
STRO
$85.6M
| $8.92M | 1.39% |
3,043,346
-1,053,273
| -26% | -$3.09M |
|
30
Scholar Rock
SRRK
$3.3B
| $8.57M | 1.33% |
+1,028,330
| New | +$8.57M |
|
31
Relay Therapeutics
RLAY
$709M
| $8.31M | 1.29% |
1,274,459
+442,442
| +53% | +$2.88M |
|
32
Cartesian Therapeutics
RNAC
$267M
| $7.01M | 1.09% |
+259,696
| New | +$7.01M |
|
33
Regenxbio
RGNX
$498M
| $6.52M | 1.01% |
557,076
+7,998
| +1% | +$93.6K |
|
|
34
Viking Therapeutics
VKTX
$3.02B
| $6.31M | 0.98% |
118,960
-31,040
| -21% | -$1.65M |
|
35
Zentalis Pharmaceuticals
ZNTL
$123M
| $5.93M | 0.92% |
1,450,000
-66,183
| -4% | -$271K |
|
36
Werewolf Therapeutics
HOWL
$62.6M
| $5.83M | 0.91% |
2,388,011
| – | – |
|
37
Repare Therapeutics
RPTX
$73.9M
| $5.41M | 0.84% |
1,639,849
| – | – |
|
38
Avidity Biosciences
RNA
$6.12B
| $5.11M | 0.79% |
+125,000
| New | +$5.11M |
|
39
Compass Therapeutics
CMPX
$466M
| $5.01M | 0.78% |
5,005,086
+3,033,684
| +154% | +$3.03M |
|
|
ADAP
40
Adaptimmune Therapeutics
ADAP
$13.9M
| $4.97M | 0.77% |
5,095,912
| – | – |
|
41
Immatics
IMTX
$662M
| $4.85M | 0.75% |
417,810
+22,573
| +6% | +$262K |
|
42
Trevi Therapeutics
TRVI
$871M
| $4.5M | 0.7% |
1,510,174
+169,214
| +13% | +$504K |
|
|
VERV
43
DELISTED
Verve Therapeutics
VERV
| $3.11M | 0.48% |
638,163
| – | – |
|
|
ALLK
44
DELISTED
Allakos
ALLK
| $345K | 0.05% |
+344,900
| New | +$345K |
|
|
45
Viridian Therapeutics
VRDN
$1.59B
| – | – |
-614,010
| Closed | -$10.8M |
|
|
46
Geron
GERN
$893M
| – | – |
-10,475,675
| Closed | -$34.6M |
|
|
47
Amicus Therapeutics
FOLD
$2.42B
| – | – |
-718,970
| Closed | -$8.47M |
|